» Articles » PMID: 14618691

The Use of Cellulase in Inhibiting Biofilm Formation from Organisms Commonly Found on Medical Implants

Overview
Journal Biofouling
Specialty Biology
Date 2003 Nov 19
PMID 14618691
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

A study was made of the use of cellulase to inhibit biofilm formation by a pathogenic bacterium commonly found in medical implants. A Pseudomonas aeruginosa biofilm was grown on glass slides in a parallel flow chamber for 4 d with glucose as the nutrient source. Biofilm development was assessed by measuring the colony forming units (CFU) and biomass areal density. Biofilm was grown at pH 5 and 7 in the presence of three different cellulase concentrations, 9.4, 37.6 and 75.2 units ml-1. In addition, a control study using deactivated cellulase was performed. The results show that cellulase is effective in partially inhibiting biomass and CFU formation by P. aeruginosa on glass surfaces. The effect of cellulase depended on concentration and was more effective at pH 5 than pH 7. The experiment was further extended by investigating the effect of cellulase on the apparent molecular weight of purified P. aeruginosa exopolysaccharides (EPS). The observation of EPS using size exclusion chromatography showed a decrease in apparent molecular weight when incubated with enzyme. An increase in the amount of reducing sugar with time when the purified EPS were incubated with enzyme also supports the hypothesis that cellulase degrades the EPS of P. aeruginosa. While cellulase does not provide total inhibition of biofilm formation, it is possible that the enzyme could be used in combination with other treatments or in combinations with other enzymes to increase effectiveness.

Citing Articles

Current Strategies for Combating Biofilm-Forming Pathogens in Clinical Healthcare-Associated Infections.

Biswas R, Jangra B, Ashok G, Ravichandiran V, Mohan U Indian J Microbiol. 2024; 64(3):781-796.

PMID: 39282194 PMC: 11399387. DOI: 10.1007/s12088-024-01221-w.


Antimicrobial therapeutic protein extraction from fruit waste and recent trends in their utilization against infections.

Upadhyay A, Pal D, Gupta P, Kumar A Bioprocess Biosyst Eng. 2024; 47(11):1767-1775.

PMID: 38822156 DOI: 10.1007/s00449-024-03037-w.


Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies.

Dsouza F, Dinesh S, Sharma S Arch Microbiol. 2024; 206(2):85.

PMID: 38300317 DOI: 10.1007/s00203-023-03802-7.


Strategy to combat biofilms: a focus on biofilm dispersal enzymes.

Wang S, Zhao Y, Breslawec A, Liang T, Deng Z, Kuperman L NPJ Biofilms Microbiomes. 2023; 9(1):63.

PMID: 37679355 PMC: 10485009. DOI: 10.1038/s41522-023-00427-y.


How Three Self-Secreted Biofilm Exopolysaccharides of , Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection.

Chung J, Eisha S, Park S, Morris A, Martin I Int J Mol Sci. 2023; 24(10).

PMID: 37240055 PMC: 10218432. DOI: 10.3390/ijms24108709.